More Evidence for New Depression Treatment

Although currently used as an off-label procedure, tDCS may soon become more widely known as a potential therapy for many ailments.  Patients have found relief from fibromyalgia, other types of chronic pain, and even depression through tDCS brain stimulation.  A recent New York Times article by Pam Belluck highlights tDCS as a potential new therapy for depression.  Read it here.

tDCS is an off-label procedure. The FDA has not cleared the equipment used in tDCS for brain treatment. Doctors are allowed to use a medical device for an off-label purpose, if, in the physician’s medical judgment, he or she believes that use of the device will benefit the patient.

To learn if tDCS or other new or alternative treatments are right for you, please contact Dr. Friedman at 561-842-PAIN (7246).